ArticleCancers2026

PARP Inhibitors Combined with Abiraterone Overcome Resistance in Metastatic Castration-Resistant Prostate Cancer Independently of Androgen Receptor.

Hamza Mallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.